Legal Representation
Attorney
Claudia A. Smith
USPTO Deadlines
Next Renewal Deadline
686 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-05-25)
Due Date
May 25, 2027
Grace Period Ends
November 25, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
21 events| Date | Code | Type | Description |
|---|---|---|---|
| May 25, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Mar 9, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 9, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Feb 17, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Feb 4, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 3, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 2, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Feb 2, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jan 12, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jan 12, 2021 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Jan 12, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jan 7, 2021 | ALIE | A | ASSIGNED TO LIE |
| Jan 7, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jan 7, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 29, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 1, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Sep 1, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Sep 1, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 31, 2020 | DOCK | D | ASSIGNED TO EXAMINER |
| Aug 11, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jul 18, 2020 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 009
Downloadable mobile application for verification of pharmaceutical preparations for patients being pharmaceutical product evaluation and testing to reduce the risk of exposure to counterfeit medicines
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Verification of pharmaceutical preparations being pharmaceutical product evaluation and testing; providing temporary use of non-downloadable mobile application software for verification of pharmaceutical preparations for patients being pharmaceutical product evaluation and testing to reduce the risk of exposure to counterfeit medicines
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
009
042